Transforming older adult disability through virtual, peer-led community rehabilitation: led by MSK charities

Good Boost Welling Limited(Good Boost)是一家快速成长的英国中小企业，提供尖端医疗技术。结合四大肌肉骨骼慈善机构和牛津布鲁克斯大学的合作、专业知识和网络接入，Good Boost独特的人工智能驱动技术有可能在2025年前为NHS GB节省1640万英镑。通过数字社区康复解决方案的扩展，该项目将产生39倍的项目后3年投资回报率。**未满足的需求**肌肉骨骼疾病(MSKD)，如关节炎和背痛，占英国不良健康负担的22%以上，每年造成经济和NHS 1000亿GB以上的损失。它们对老年人、低收入者和BAME公民的影响不成比例，造成了严重的健康不平等。MSKD患病率正在上升，等待时间增加，处理COVID后积压的重大挑战摆在面前。需要解决方案来提供不需要额外NHS资源的MSK康复。MSK慈善机构受到临床医生和患者的信任，是提供离家更近的护理的首要支持服务，与NHS战略保持一致。然而，由于有1880万MSK患者，没有足够的临床工作人员或志愿者为所有人提供康复服务。Good Boost创新的AI MSK康复技术将使慈善机构能够通过工作人员和志愿者提供虚拟团体康复课程。每个用户都将从人工智能个性化程序中受益。到目前为止，已经与患者和慈善焦点小组共同设计和制作了MVP解决方案。这笔资金将支持对真实世界试点的工业研究，以进一步开发、测试和验证临床技术，使其能够在2022年在全国推出，并满足迫切需求。**市场机会**虽然市场上有人工智能康复产品，但没有一个提供基于虚拟社区的解决方案。事实证明，情感支持和同伴支持可以显著提高接受能力和持续参与度。此外，没有任何产品与MSK慈善机构合作。由于老年人需要高信任度才能下载和使用健康应用程序，MSK慈善合作有可能显著扩大覆盖范围和影响力。全球24.1亿人需要康复(WHO)，这是一个巨大的国际商机。全球和英国的年度可定位/可服务市场分别为GB 15.4B/GB 4.65B和GB 0.51B/GB 0.32B。**目标**这个工业研究项目旨在完成产品测试、联合生产和研究，以获得项目后3-6个月公开推出和商业化的监管批准，创造一种公众可接触的产品，以满足MSKD的临床康复需求，并减少健康不平等。

Good Boost Wellbeing Limited (Good Boost) is a rapidly growing UK SME delivering cutting-edge medical technology. Combined with the collaboration, expertise and network access of the four largest musculoskeletal charities\* and Oxford Brookes University, Good Boost's unique AI-powered technology has the potential to save the NHS £16.4m by 2025\. Through the expansion of digital community rehabilitation solutions, the project stands to generate a Year-3 post-project ROI of 39X. \*(Versus Arthritis, National Rheumatoid Arthritis Society, Arthritis Action, National Axial Spondyloarthropathy Society.)**Unmet Need**Musculoskeletal disorders (MSKDs), such as arthritis and back pain represent over 22% of the ill-health burden in the UK, costing the economy and NHS £100bn+ per year. Disproportionately impacting older adults, low income and BAME citizens, they create deep health inequalities. MSKD prevalence is rising, waiting times increasing and significant challenges are ahead to address backlogs post-COVID. Solutions are needed to deliver MSK-rehabilitation that don't require additional NHS resources.Trusted by clinicians and patients, MSK charities are the foremost support service to deliver care closer to home, aligning with the NHS strategy. However, with 18.8m people living with an MSK condition, there are not enough clinical staff or volunteers to provide rehabilitation services for all.**Solution**Good Boost's innovative AI MSK-rehabilitation technology will enable charities to deliver virtual group rehab classes through staff and volunteers. Every user will benefit from an AI-personalised programme. To date, an MVP solution has been co-designed and co-produced with patient and charity focus groups. This funding will support industrial research of a real-world pilot to further develop, test and validate the clinical technology, enabling national roll-out in 2022, and meeting the urgent need.**Market Opportunity**While there are AI-rehab products on the market, none deliver virtual community-based solutions. Emotional and peer support is proven to significantly improve uptake and continued engagement. Furthermore, no products work collaboratively with MSK charities. With older adults requiring high trust levels to download and use health apps, MSK charity collaboration has the potential to significantly increase reach and impact.2.41bn people need rehabilitation globally (WHO) representing a large international commercial opportunity. The annual global and UK addressable/serviceable markets are £15.4b/£4.65b and £0.51b/£0.32b respectively. CAGR is 7.7%.**Objectives**This industrial research project aims to complete product testing, co-production and research to achieve regulatory approval for public rollout and commercialisation 3-6 months post-project, to create a publically-accessible product which will address clinical rehab needs for MSKDs, and reduce health inequality.